An unusual initial presentation of mantle cell lymphoma arising from the lymphoid stroma of warthin tumor
© Arcega et al. 2015
Received: 16 October 2015
Accepted: 28 November 2015
Published: 3 December 2015
Warthin tumors presenting concomitantly with a lymphoma is vanishingly rare with only 15 reported cases in English literature. Herein, we report an unusual initial presentation of a mantle cell lymphoma involving the lymphoid stroma of a Warthin tumor.
A seventy-seven year old otherwise healthy gentleman with a 50-pack year smoking history presents with a slowly enlarging left cheek mass. CT scan of the neck demonstrated a left parotid gland tumor measuring 3.4 cm in greatest dimension. He underwent a left superficial parotidectomy, with subsequent histopathologic examination revealing a Warthin tumor with extensive expansion of the lymphoid stroma. Flow cytometric, immunohistochemical, and cytogenetic studies of the stromal component of the tumor confirmed the presence of a mantle cell lymphoma. Clinical staging demonstrated stage IVa disease, and was considered to be at low to intermediate risk due to the slow growth of the parotid lesion. The patient is undergoing close follow up with repeat PET-CT scans at six months.
To the best of our knowledge, this is the first well documented collision tumor between mantle cell lymphoma and a Warthin tumor. This case also brings to light the significance of thorough evaluation of the lymphoid component of Warthin tumor.
KeywordsMantle cell lymphoma Warthin tumor Collision tumor
Warthin tumor is the second most common benign tumor of the salivary gland . The tumor is characterized by an epithelial component composed mainly of tall bilayered oncocytic columnar cells embedded within a lymphoid stroma [1, 2]. Lymphoma involving the stromal component is extremely rare, with the majority of those that have been described are in the setting of a widely disseminated lymphoma. Herein we describe a case of mantle cell lymphoma that primarily presented as part of the Warthin Tumor (i.e., a collision tumor). Karyotype studies detected the characteristic t(11;14)(q13;q32) translocation as part of a complex karyotype, and corroborated by immunohistochemistry studies. This case emphasizes the importance of a thorough evaluation of the lymphoid stroma of a Warthin Tumor, since the lymphoma cells can be easily confused with a normal reactive lymphoid component within the tumor.
Summary of 15 cases of non-Hodgkin lymphoma involving Warthin tumor
Colby and Dorfman (1979)
Bunker and Locker (1989)
Giardini and Mastore (1990)
Left and Right Parotid
Warthin tumors are the second most common benign salivary gland tumor, with an average age at presentation of 62 years old, and have rarely been described before the age of 40 . A strong association between smoking and Warthin tumors has been described, with an estimated incidence of eight times compared to that of nonsmokers . The male to female ratio was 10:1 in 1953, whereas it was 1.2:1 in 1996 , which parallels the larger number of female smokers during this period . Despite quitting smoking a few years prior to his presentation, our patient had an established 50-pack year smoking history. The patient denied other possible risk factors that have been linked to Warthin tumors, such as radiation exposure and autoimmune disorder.
Biologically it is quite feasible that lymphomas may arise within a Warthin tumor, since the lymphoid stroma is part of the systemic lymphoid tissue, and hence may be involved in disseminated lymphomatous involvement. Of the reported cases of lymphomas within Warthin tumors, the majority of patients either already had an established diagnosis at presentation, or systemic involvement was discovered at staging after initial diagnosis in the Warthin tumor.
Although patients with mantle cell lymphoma have a median survival of 3–5 years, with the vast majority of these patients not cured despite treatment , the prognosis of those which arise from within the confines of another tumor is virtually unknown. The most consistent histopathologic prognostic parameter is a high mitotic rate, which is defined as 10–37.5/15 hpf, with a high proportion of Ki67 positive cells (>40 % to 60 %) also an adverse prognostic indicator . Blastoid and pleomorphic morphology, trisomy 12, and karyotypic complexity(≥ three or more chromosomal aberrations), have all been reported to have adverse prognostic features . Despite the lack of observed mitotic activity in the current case, the Ki67 proliferative index was estimated to be 40 %. Blastoid and pleomorphic morphology was not evident. Although gains of chromosome 3q and deletions of 9q, both associated with poor prognosis were not seen in the current case, a complex karyotype was observed.
A thorough clinical staging is warranted in patients with mantle cell lymphoma, since most patients present with stage III or IV disease . The patient was referred to his local medical oncologist. He had whole body diagnostic and contrast-enhanced CT imaging followed by FDG administration and PET image acquisition, which disclosed hypermetabolism in the left parotid area and a single liver lesion, likely representing metastatic disease, without other adenopathy. Bone marrow biopsy revealed 2 % involvement by B-cell lymphoma. He was staged as Stage IVa. Patient was considered to be at low-intermediate risk due to the slow growth of the parotid lesion, and elected to undergo close observation with plans for repeat PET-CT at 6 months.
In summary, initial presentation of a malignant lymphoma within the lymphoid stroma of a Warthin tumor is extremely rare. This is the first reported case of a collision tumor presenting with mantle cell lymphoma and Warthin tumor. Emphasis must be made for a thorough examination of the lymphoid component in a Warthin tumor as clearly exemplified by our case.
Written informed consent was obtained from the patient for publication of this Case Report and is available upon request.
We thank Dr. Haodong Xu and Dr. Fernando Palma-Diaz for their expert opinion.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Eveson JW, Simpson RHW. Warthin tumour. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification of tumours: Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 263–5.Google Scholar
- Gnepp DR, Henley JD, Simpson RHW, Eveson J. Salivary and Lacrimal Glands. In: Gnepp DR, Editor. Diagnostic Surgical Pathology of the Head and Neck. Philadelphia: Saunders Elsevier, 2009. p. 453–456.Google Scholar
- Colby TV, Dorfman RF. Malignant lymphomas involving the salivary glands. Pathol Annu. 1978;14(Pt 2):307–24.Google Scholar
- Miller R, Yanagihara ET, Dubrow AA, Lukes RJ. Malignant lymphoma in the Warthin’s tumor report of a case. Cancer. 1982;50(12):2948–50.View ArticlePubMedGoogle Scholar
- Hall G, Tesluk H, Baron S. Lymphoma arising in an adenolymphoma. Hum Pathol. 1985;16(4):424–7.View ArticlePubMedGoogle Scholar
- Banik S, Howell JS, Wright DH. Non-Hodgkin’s lymphoma arising in adenolymphoma-a report of two cases. J Pathol. 1985;146(3):167–77.View ArticlePubMedGoogle Scholar
- Griesser GH, Hansmann ML, Bogman MJ, Pielsticker K, Lennert K. Germinal center derived malignant lymphoma in cystadenolymphoma. Virchows Arch A Pathol Anat Histopathol. 1986;408(5):491–6.View ArticlePubMedGoogle Scholar
- Melato M, Falconieri G, Fanin R, Baccarani M. Hodgkin’s disease occurring in a Warthin’s tumor: first case report. Pathol Res Pract. 1986;181(5):615–20.View ArticlePubMedGoogle Scholar
- Bunker ML, Locker J. Warthin’s tumor with malignant lymphoma. DNA analysis of paraffin-embedded tissue. Am J Clin Pathol. 1989;91(3):341–4.PubMedGoogle Scholar
- Giardini R, Mastore M. Follicular non Hodgkin’s lymphoma in adenolymphoma: report of a case. Tumori. 1990;76(2):212–5.PubMedGoogle Scholar
- Medeiros LJ, Rizzi R, Lardelli P, Jaffe ES. Malignant lymphoma involving a Warthin’s tumor: a case with immunophenotypic and gene rearrangement analysis. Hum Pathol. 1990;21(9):974–7.View ArticlePubMedGoogle Scholar
- Shikhani AH, Shikhani LT, Kuhajda FP, Allam CK. Warthin’s tumor-associated neoplasms: report of two cases and review of the literature. Ear Nose Throat J. 1993;72(4):264–9. 272–273.PubMedGoogle Scholar
- Park CK, Manning JT, Battifora H, Medeiros LJ. Follicle center lymphoma and Warthin tumor involving the same anatomic site: Report of two cases and review of the literature. Am J Clin Pathol. 2000;113(1):113–9.View ArticlePubMedGoogle Scholar
- Saxena A, Memauri B, Hasegawa W. Initial diagnosis of small lymphocytic lymphoma in parotidectomy for Warthin tumour, a rare collision tumour. J Clin Pathol. 2005;58(3):331–3.PubMed CentralView ArticlePubMedGoogle Scholar
- Giaslakiotis K, Androulaki A, Panagoulias G, et al. T cell lymphoblastic lymphoma in parotidectomy for Warthin’s tumor: case report and review of the literature. Int J Hematol. 2009;89(3):359–64.View ArticlePubMedGoogle Scholar
- Seifert G, Bull HG. A Histologic Subclassification of the Cystadenolymphoma of the Parotid Gland. Virchows Arch A Pathol Anat Histol. 1980;388:13–38.Google Scholar
- Kotwall CA. Smoking as an etiologic factor in the development of Warthin’s tumor of the parotid gland. Am J Surg. 1992;164(6):646–7.View ArticlePubMedGoogle Scholar
- Swerdlow SH, Campo E, Seto M, Müller-Hermelink HK. Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 229–32.Google Scholar